Aigen Investment Management’s Cymabay Therapeutics CBAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-42,267
Closed -$463K 1139
2023
Q2
$463K Buy
+42,267
New +$463K 0.07% 372
2021
Q1
Sell
-10,785
Closed -$62K 942
2020
Q4
$62K Buy
+10,785
New +$62K 0.01% 742